Following a ghastly accident that had him battling for his life in a Lagos hospital, Nigerian rap artiste, Sodiq Abubakar Yusuf, better known as CDQ, is currently confined to a wheelchair.
The accident reportedly occurred in Lagos on Tuesday afternoon. According to eyewitnesses, the rapper’s car rammed into a building along the road after it was hit by another car.
Fans and well-wishers took to the comment section of his social media handle to wish him a quick recovery.
However, giving an update on his recovery, the rapper posted a photograph of himself in a wheelchair. CDQ, all smiles, captioned it “Que sera sera”, meaning what will be will be.
Born May 6, 1985, CDQ is a Nigerian indigenous hip-hop rapper and songwriter best known for his single ‘Nowo E Soke’ featuring Wizkid. He is also known for Masterkraft’s ‘Indomie’ where he was featured alongside Olamide.
“While the former is instrumental in launching his career into the Nigerian music industry, the latter won him his first career award at the 2016 Nigerian Music Video Awards.
Signed to his label No Struggle No Success Entertainment, CDQ’s repertoire of music includes rapping in the Yoruba language with the addition of ad-libs such as the popular ‘Woss Wobi’ which he invented.
Professionally, CDQ’s music career started in 2008 as a backup singer for Da Grin before he started rapping in English Language with M.I. In 2012, he collaborated with M.I Abaga and won a rap battle contest, which brought him into the limelight.
In 2013, he signed a recording contract with Masterkraft’s General Records. In 2014, he released his breakthrough single titled ‘Indomie’ which featured vocals from Olamide while the remix of the song featured Davido. The song earned him two nomination spots at the 2015 Nigeria Entertainment Awards and a nomination in the Best Street-Hop Artist category at The Headies 2015.
We do everything possible to supply quality news and information to all our valuable readers day in, day out and we are committed to keep doing this. Your kind donation will help our continuous research efforts.